August 1, 2022

FDA: Class I recall of Covidien’s Palindrome, Mahurkar hemodialysis catheters

By: Judy Mathias

Editor's Note

The Food and Drug Administration (FDA) on July 28 identified the recall by Covidien, LLC (Medtronic) of its Palindrome and Mahurkar hemodialysis catheters as Class I, the most serious.

The recall was initiated because of a catheter hub defect that connects both extension catheters. There is a potential leaking in the hub, which could result in the mixing of arterial and venous blood, increased recirculation and poor dialysis, and the development of thrombi and emboli.

There has been one complaint and no reports of injuries or deaths. Distribution dates were June 28, 2017, to May 11, 2022.


Join our community

Learn More
Video Spotlight
Live chat by BoldChat